Robert W. Wilmott - Concepedia

Author

Robert W. Wilmott

Cincinnati Children's Hospital Medical Center ORCID

Also Known As

Monica Helton, Philip Hashkes, R Pitcher-Wilmott, R W Pitcher-Wilmott, R W Wilmott, R WILMOTT, R Wilmott, R.W Wilmott, R.W. Wilmott, ROBERT W WILMOTT

353

Publications

5.1K

Citations

H-Index

107

Concepts

All Affiliations

Cincinnati Children's Hospital Medical Center University of Cincinnati University of Cincinnati Medical Center University of Pennsylvania Seattle Children's Hospital

About

Robert W. Wilmott is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, pulmonary fibrosis, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	34	2.8K
2	Allergy	6	6	422
3	Health Sciences	5	5	880
4	Public Health	3	3	215
5	Natural Sciences	1	1	68

Robert W. Wilmott

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis Bonnie W. Ramsey, Henry L. Dorkin, Jay D. Eisenberg, New England Journal of Medicine Health SciencesPulmonary FunctionPharmacologyRespiratory InfectionInfectious Respiratory Disease	1993	454
High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests Alan S. Brody, Jeffrey S. Klein, Paul L. Molina, The Journal of Pediatrics Pulmonary Function TestsMedical ImagingAdvanced Lung DiseasePediatricsDiagnosis	2004	350
Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis Maria T. Britto, Uma R. Kotagal, Richard Hornung, CHEST Journal Pulmonary CareInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationRecent Pulmonary Exacerbations	2002	345
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis Ronald L. Gibson, Julia Emerson, Sharon McNamara, American Journal of Respiratory and Critical Care Medicine AntibioticsInhaled TobramycinPediatricsRespiratory InfectionPediatric Lung Disease	2003	314
Variant Cystic Fibrosis Phenotypes in the Absence of<i>CFTR</i>Mutations Joshua D. Groman, Michelle E. Meyer, Robert W. Wilmott, New England Journal of Medicine	2002	176
<i>In Vivo</i> Evaluation of the Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lung Soonpin Yei, Nanette Mittereder, Susan E. Wert, Human Gene Therapy	1994	173
The placental transfer of IgG subclasses in human pregnancy. Robert W. Wilmott, P. Hindocha, Christine Wood PubMed ImmunologyGynecologyEmbryologyHigh-risk PregnancyMaternal Immunization	1980	147
Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis Arnold L. Smith, Gregory J. Redding, Carl F. Doershuk, The Journal of Pediatrics AllergyEndobronchial ExacerbationPathologyPulmonary FibrosisMedicine	1988	146
Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis Arnold L. Smith, Carl F. Doershuk, Donald A. Goldmann, The Journal of Pediatrics	1999	141
Improved survival among young patients with cystic fibrosis Michal Kulich, Margaret Rosenfeld, Christopher H. Goss, The Journal of Pediatrics Disease Progression	2003	129

Page 1